dihydroquercetin,
taxifolin,
TAXIFOLIN,
(+)-Taxifolin,
480-18-2,
dihydroquercetin,
Distylin,
Taxifoliol,
(2R,3R)-Dihydroquercetin,
(+)-Dihydroquercetin,
TAXIFOLIN-(+),
Lariksin,
Lavitol,
taxifolin (dihydroquercetin),
3,5,7,3',4'-Pentahydroxyflavanone,
UNII-9SOB9E3987,
4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-,
trans-Dihydroquercetin,
(+)-trans-Taxifolin,
(2R,3R)-2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-2,3-DIHYDRO-4H-CHROMEN-4-ONE,
(2R,3R)-3,3',4',5,7-Pentahydroxyflavanone,
24198-97-8,
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychroman-4-one,
2,3-Dihydroquercetin,
(2R-trans)-2-(3,4-Dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4-benzopyrone,
(2R,3R)-(+)-Taxifolin,
17654-26-1,
CHEBI:17948,
(+)-(2R,3R)-dihydroquercetin,
CXQWRCVTCMQVQX-LSDHHAIUSA-N,
9SOB9E3987,
MFCD00006845,
(+/-)-Taxifolin,
(2R,3R)-TRANS-DIHYDROQUERCETIN,
Flavanone, 3,3',4',5,7-pentahydroxy-,
Dihydroquercetin hydrate,
Diquertin,
EINECS 207-543-4,
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chroman-4-one,
Flamena D,
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one,
(2R,3R)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one,
BRN 0093548,
20254-28-8,
DQH,
SMR000466389,
4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-,
Flavone, 2,3-dihydro-3,3',4',5,7-pentahydroxy-,
CCRIS 9292,
Taxifolin (Tax),
AK146105,
(+)-trans Taxifolin,
Taxifolin, (+/-)-,
(+/-)-Taxifolin hydrate,
Taxifolin(Dihydroquercetin),
AC1L97JB,
Dihydroquercetin, (+/-)-,
SCHEMBL39786,
5-18-05-00451 (Beilstein Handbook Reference),
MLS000759539,
MLS001066341,
MLS001074712,
MLS001424044,
MLS002153142,
BIDD:ER0483,
Taxifolin, analytical standard,
AC1Q59H1,
MEGxp0_000741,
DTXSID8022450,
ACon1_000239,
CTK4E3671,
BDBM212435,
HMS2051M22,
HMS2234L14,
98006-93-0,
HY-N0136,
taxifolin solution, 20 mM in DMSO,
AC-935,
MFCD11044454,
s2366,
AKOS015965399,
ZINC100018343,
API0004327,
CCG-100909,
CS-3365,
DB02224,
KS-1312,
MCULE-2394173874,
MCULE-2692728789,
NC00159,
RL03789,
KS-00000L93,
NCGC00180750-01,
AJ-11151,
AN-15433,
AS-17723,
BC216327,
CC-26825,
CPD000466389,
SAM001246778,
SC-85873,
ZB003533,
(+)-3,3',4',5,7-Pentahydroxyflavanone,
dihydroquercetin solution, 20 mM in DMSO,
3,3',4',5,7-Pentahydroxyflavanone hydrate,
FT-0080642,
FT-0604481,
FT-0638403,
FT-0650551,
SW197539-2,
V1551,
Taxifolin, disposable screening library format,
(+)-trans-Taxifolin solution, 20 mM in DMSO,
C01617,
C-25526,
SR-01000759385,
Flavanone, 3,3',4',5,7-pentahydroxy-, (R,R)-,
J-011205,
SR-01000759385-6,
Taxifolin, primary pharmaceutical reference standard,
F40AB773-26FA-4112-A46D-DC970AF64BC1,
Flavanone, 3,3',4',5,7-pentahydroxy-, (2R)-trans-,
Flavanone, 3,3',4',5,7-pentahydroxy-, trans-(+)-,
Flavanone, 3,3',4',5,7-pentahydroxy-, (2R,3R)-(+)-,
UNII-EAS93SC1VS component CXQWRCVTCMQVQX-LSDHHAIUSA-N,
Taxifolin; 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chroman-4-one,
(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-4-one,
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4H-chromen-4-one, (2R-trans)-,
4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-,
4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R-trans)-,
4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, trans-(+/-)-,
4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-rel-,
Catechin hydrate,
Cianidanol,
Quercetin, dihydro-,
(+/-)-dihydroquercetin,
CHEMBL66,
UNII-EAS93SC1VS,
EAS93SC1VS,
C15H12O7,
3,3',4',5,7-Pentahydroxyflavanone,
CID439533,
ACN-035776,
C15-H12-O7,
CS-M-48166,
(2S,3S)-TRANS-DIHYDROQUERCETIN,
( )-Taxifolin, 98% - 100MG 100mg,
A10893,
C003377,
6270-97-9,